TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ABEO

Abeona Therapeutics Inc

Healthcare · Biotechnology

5.60$ -0.4% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Abeona Therapeutics Inc (ABEO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 220 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ABEO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
17 80 111 179 174 223 151 80 64 64 109 220
12 41 69 141 89 132 98 56 53 56 101 205
12 40 69 138 19 129 13 33 14 14 23 78
12 40 69 138 85 129 95 45 52 52 98 191
0.0 0.1 0.1 0.1 0.1 0.0 0.0 3.0 0.2 2.4 1.7 6.7
0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 5.5
0.0 0.4 0.7 1.4 9.4 13 18 22 11
0.0 32 32 32 32 32 32 0.0
5.0 6.6 8.4 4.0 43 36 1.5 1.4
12 12 12 8.7 40 45 49 37 37 49 65 60
2.9 1.5 8.3 5.6 20 39 42 17 7.8 13 17 30
0.4 -0.6 -3.7 10 1.7 2.0 1.8 1.8 1.0 6.7 13
1.9 0.9 3.7 1.9 6.1 3.8 4.7 4.3 1.8 1.9 3.4 7.9
0.0 0.0 0.0 0.0 20 1.4 13 7.8
4.8 68 99 170 134 178 103 42 27 15 44 159
-296 -311 -332 -360 -410 -486 -571 -656 -695 -750 -813 -742
0.0 1.1 1.4 1.7 1.9 2.0 3.7 3.9 7.9 21 41 66

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?